CVS Health (NYSE: CVS) reported Q1 EPS of $1.62, $0.12 better than the analyst estimate of $1.50. Revenue for the quarter came in at $61.6 billion versus the consensus estimate of $60.47 billion.

GUIDANCE:

CVS Health sees FY2019 EPS of $6.75-$6.90, versus the consensus of $6.77.

For earnings history and earnings-related data on CVS Health (CVS) click here.